Michael Brophy serves as the Chief Financial Officer at Natera, Inc., a position he has held since joining the company in 2014. In his role, Brophy is responsible for overseeing the financial operations and strategy of the company, which specializes in genetic testing and diagnostics. His leadership has been instrumental in guiding Natera through significant growth and expansion, helping to solidify its position as a leader in the field of personalized medicine. Prior to joining Natera, Brophy amassed a wealth of experience in the life sciences and healthcare industries. He previously served as the CFO of OptiScan Biomedical Corporation, where he played a key role in the company's financial planning and investor relations. Brophy also held senior financial positions at companies such as Ventana Medical Systems and Bayer Healthcare, where he honed his skills in financial management and strategic planning. His extensive background has been a valuable asset to Natera, enabling the company to navigate the complex financial landscape of the healthcare industry. Under Brophy's stewardship, Natera has achieved several notable milestones, including the successful launch of new genetic testing products and the expansion of its global presence. His strategic vision and financial acumen have been crucial in securing funding and partnerships that have fueled the company's growth. Brophy's contributions have not only strengthened Natera's financial position but have also supported the company's mission to improve patient outcomes through innovative genetic testing solutions.